Masaki, Nobuyuki <br/><br/>
Optimal two-stage designs allowing flexibility in number of subjects for phase II clinical trials.  [electronic resource] 

 -  Journal of biopharmaceutical statistics  Jul 2009 
 - 721-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1520-5711 
<br/><br/><label>Standard No.: </label>10.1080/10543400902964167  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials, Phase II as Topic--statistics & numerical data<br/>Computer Simulation<br/>Data Interpretation, Statistical<br/>Humans<br/>Models, Statistical<br/>Sample Size<br/>Treatment Outcome